Cancer Screening: Guidelines, Tests, and Recommendations

What Is Cancer Screening?

Cancer screening refers to tests performed on people who have no symptoms of cancer, with the goal of detecting cancer at an early, more treatable stage. Some screening tests can even find precancerous changes before they develop into cancer, allowing for prevention rather than just early treatment.

Not all cancers have effective screening tests. The major organizations that develop screening guidelines, the American Cancer Society (ACS) and the U.S. Preventive Services Task Force (USPSTF), evaluate the scientific evidence to determine which screening tests provide a net benefit, meaning the benefits of early detection outweigh the potential harms of false positives, overdiagnosis, and follow-up procedures.

Breast Cancer Screening

Mammography

Mammography is the primary screening tool for breast cancer. It uses low-dose X-rays to create detailed images of breast tissue, allowing radiologists to detect tumors too small to feel on physical examination.

Higher-risk women (BRCA1/2 mutation carriers, strong family history, prior chest radiation) may need to begin screening earlier (often age 25-30) and may benefit from breast MRI in addition to mammography. Discuss your personal risk with your doctor.

Colorectal Cancer Screening

Colorectal cancer screening is one of the most effective cancer prevention strategies because it can detect and remove precancerous polyps before they become cancer.

Screening Options

• Colonoscopy: The gold standard. A flexible scope examines the entire colon, and polyps can be removed during the procedure. Recommended every 10 years for average-risk individuals.
• Stool-based tests: Fecal immunochemical test (FIT) detects hidden blood in stool (annually). FIT-DNA test (Cologuard) detects blood and altered DNA (every 3 years). Positive results require a follow-up colonoscopy.
• CT colonography (virtual colonoscopy): Uses CT imaging to view the colon. Recommended every 5 years. Polyps found require a standard colonoscopy for removal.
• Flexible sigmoidoscopy: Examines the lower third of the colon. Every 5 years (or every 10 years if combined with annual FIT).

Cervical Cancer Screening

Cervical cancer screening has dramatically reduced cervical cancer incidence and mortality. Screening involves the Pap test (Pap smear), HPV testing, or both.

• Ages 21-29: Pap test every 3 years. HPV testing alone is not recommended in this age group (USPSTF).
• Ages 30-65: Three options: Pap test alone every 3 years, HPV test alone every 5 years, or co-testing (Pap + HPV) every 5 years.
• After age 65: Screening can stop if adequate prior screening has been normal and no high-risk factors exist.
• After total hysterectomy: Screening can stop if the hysterectomy was for non-cancerous reasons and there is no history of cervical precancer.

The HPV vaccine has dramatically reduced the incidence of HPV infections that cause cervical cancer, but vaccinated individuals should still follow screening guidelines.

Prostate Cancer Screening

Prostate-specific antigen (PSA) screening for prostate cancer is one of the more nuanced screening decisions because of the risk of overdiagnosis: detecting slow-growing cancers that would never cause symptoms or death during a person's lifetime.

• ACS recommendation: Informed decision-making discussion starting at age 50 for average-risk men (age 45 for African American men or those with a first-degree relative diagnosed before 65; age 40 for those with multiple first-degree relatives diagnosed early).
• USPSTF recommendation: For men ages 55-69, the decision to be screened should be an individual one after discussing the potential benefits and harms with a doctor. Not recommended for men 70 and older.

If you and your doctor decide on PSA screening, it is typically done every one to two years. A PSA level above 4.0 ng/mL may prompt further evaluation, though PSA can be elevated for non-cancerous reasons such as an enlarged prostate (BPH) or infection.

Lung Cancer Screening

Low-dose computed tomography (LDCT) is the only recommended screening test for lung cancer. It is targeted to individuals at highest risk based on smoking history.

Who Should Be Screened

• USPSTF: Adults ages 50-80 who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years.
• ACS: Adults ages 50-80 who have a 20+ pack-year smoking history and currently smoke or have quit within the past 15 years.

Screening should be discontinued once a person has not smoked for 15 years or develops a health condition that substantially limits life expectancy or the ability to have curative lung surgery. Annual LDCT screening in eligible individuals reduces lung cancer mortality by approximately 20% compared to chest X-ray.

Skin Cancer Checks

There is no formal USPSTF or ACS recommendation for routine skin cancer screening in the general population. However, dermatologists and many primary care physicians recommend regular skin examinations, especially for people with risk factors.

• Monthly self-exams: Check your entire body for new moles, changes in existing moles, or sores that do not heal. Use the ABCDE rule: Asymmetry, Border irregularity, Color variation, Diameter greater than 6mm, Evolving size/shape/color.
• Clinical skin exams: Consider annual full-body skin exams with a dermatologist if you have a personal or family history of skin cancer, many moles, fair skin, or a history of significant sun exposure or tanning bed use.

Other Screenings to Discuss With Your Doctor

• Liver cancer: Ultrasound and alpha-fetoprotein (AFP) blood test every 6 months for people with cirrhosis or chronic hepatitis B
• Ovarian cancer: No effective routine screening for average-risk women. Women with BRCA mutations or strong family history may discuss CA-125 blood test and transvaginal ultrasound with a genetic counselor.
• Endometrial cancer: No routine screening for average-risk women. Women with Lynch syndrome should discuss annual endometrial biopsy starting at age 35.

Risk Factors That Change Your Screening Schedule

Certain factors may mean you need to start screening earlier or be screened more frequently than the general population:

• Family history: First-degree relatives with cancer, especially if diagnosed young
• Genetic mutations: BRCA1/2, Lynch syndrome (HNPCC), Li-Fraumeni syndrome, familial adenomatous polyposis (FAP)
• Prior radiation therapy: Chest radiation before age 30 increases breast cancer risk
• Personal history: Previous cancer, precancerous conditions, or inflammatory bowel disease
• Lifestyle factors: Smoking history (lung cancer), heavy alcohol use (liver cancer), obesity (several cancers)

If you have any of these risk factors, ask your doctor or a genetic counselor about personalized screening recommendations. Genetic testing may help clarify your risk level and guide screening decisions.

Understanding Your Screening Results

Screening tests are not diagnostic tests. A positive or abnormal screening result does not necessarily mean you have cancer. It means further evaluation is needed, which may include additional imaging, blood tests, or a biopsy.

• True positive: The screening correctly identified a cancer or precancerous condition
• False positive: The screening suggested an abnormality that turned out not to be cancer after further testing. This is relatively common and can cause anxiety and lead to unnecessary procedures.
• True negative: The screening correctly showed no cancer
• False negative: The screening missed a cancer that was present. No screening test is 100% accurate.

Discuss your results thoroughly with your doctor. If something abnormal is found, understand the recommended next steps and timeline for follow-up.

Last reviewed: March 2026. Screening guidelines are updated periodically. Always consult your healthcare provider for the most current recommendations based on your individual risk factors.